Fusion Cell Vaccination In Conjunction With Stem Cell Transplantation Is Well Tolerated, Induces Anti-Tumor Immunity and Is Associated With Responses In Patients With Multiple Myeloma

David Avigan(Beth Israel Deaconess Medical Center), Donald Küfe(Dana-Farber Cancer Institute), Donna Fitzgerald(Beth Israel Deaconess Medical Center), Poorvi Somaiya(Beth Israel Deaconess Medical Center), Vassiliki A. Boussiotis(Beth Israel Deaconess Medical Center), Michal Tsumer(Rambam Health Care Campus), Adam Bissonnette(Dana-Farber Cancer Institute), Robin Joyce(Beth Israel Deaconess Medical Center), Kenneth C. Anderson(Dana-Farber Cancer Institute), Lynne Uhl(Hadassah Medical Center), Paul G. Richardson(Harvard University), Nikhil C. Munshi(Dana-Farber Cancer Institute), Claire MacNamara, Jacalyn Rosenblatt(Beth Israel Deaconess Medical Center), Jamie Mortellite(Beth Israel Deaconess Medical Center), Jacob M. Rowe(Technion – Israel Institute of Technology), Baldev Vasir(Beth Israel Deaconess Medical Center), Karen Lowe, Katharine Conway(Beth Israel Deaconess Medical Center), Irit Avivi(Tel Aviv Sourasky Medical Center), L. Bishart(Rambam Health Care Campus), Dilani Dombagoda(Beth Israel Deaconess Medical Center), Corrine Zarwan(Beth Israel Deaconess Medical Center), Nancy Giallombardo(Beth Israel Deaconess Medical Center), Z. Wu(Dana-Farber Cancer Institute), Terry Katz(Rambam Health Care Campus), James D. Levine(Beth Israel Deaconess Medical Center), D. Tzachanis(Beth Israel Deaconess Medical Center)

Transplantation and Cellular Therapy

January 23, 2009

Cited by 0

|Nature|2013|10.1k

|New England Journal of Medicine|2017|6k

|Nature Immunology|2001|3k

|New England Journal of Medicine|2003|2.6k

|Leukemia|2006|2.6k

Related Papers